- Home
- YETI vs JANX Comparison
YETI vs JANX Comparison
Compare YETI & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- JANX
- Stock Information
- Founded
- YETI 2006
- JANX 2017
- Country
- YETI United States
- JANX United States
- Employees
- YETI N/A
- JANX N/A
- Industry
- YETI Recreational Games/Products/Toys
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- YETI Consumer Discretionary
- JANX Health Care
- Exchange
- YETI Nasdaq
- JANX Nasdaq
- Market Cap
- YETI 3.2B
- JANX 2.2B
- IPO Year
- YETI 2018
- JANX 2021
- Fundamental
- Price
- YETI $33.69
- JANX $26.81
- Analyst Decision
- YETI Hold
- JANX Strong Buy
- Analyst Count
- YETI 13
- JANX 8
- Target Price
- YETI $45.00
- JANX $91.25
- AVG Volume (30 Days)
- YETI 1.7M
- JANX 784.7K
- Earning Date
- YETI 05-08-2025
- JANX 05-06-2025
- Dividend Yield
- YETI N/A
- JANX N/A
- EPS Growth
- YETI 5.67
- JANX N/A
- EPS
- YETI 2.05
- JANX N/A
- Revenue
- YETI $1,829,873,000.00
- JANX $10,588,000.00
- Revenue This Year
- YETI $8.53
- JANX N/A
- Revenue Next Year
- YETI $6.14
- JANX $289.47
- P/E Ratio
- YETI $16.15
- JANX N/A
- Revenue Growth
- YETI 10.32
- JANX 30.99
- 52 Week Low
- YETI $31.48
- JANX $26.39
- 52 Week High
- YETI $45.25
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- YETI 43.51
- JANX 29.87
- Support Level
- YETI $32.51
- JANX $29.77
- Resistance Level
- YETI $34.17
- JANX $32.00
- Average True Range (ATR)
- YETI 1.28
- JANX 1.44
- MACD
- YETI 0.06
- JANX -0.00
- Stochastic Oscillator
- YETI 52.87
- JANX 7.01
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.